COST-EFFECTIVENESS ANALYSIS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR VERSUS CLOPIDOGREL IN HONG KONG: A MARKOV ANALYTIC MODEL

被引:0
|
作者
Lee, V. W. Y. [1 ]
Chow, I. H. I. [1 ]
Yan, B. P. [2 ,3 ]
Yu, C. M. [1 ]
Lam, Y. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Monash Univ, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1016/j.jval.2012.08.993
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A371 / A371
页数:1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN TREATING PATIENTS WITH ACUTE CORONARY SYNDROME IN HONG KONG
    Wu, D. B. C.
    Lee, B. S. C.
    Lee, K. K. C.
    VALUE IN HEALTH, 2014, 17 (07) : A487 - A487
  • [2] Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
    Grima, Daniel T.
    Brown, Stephen T.
    Kamboj, Laveena
    Bainey, Kevin R.
    Goeree, Ron
    Oh, Paul
    Ramanathan, Krishnan
    Goodman, Shaun G.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 49 - 62
  • [3] Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
    Gasche, David
    Ulle, Tanja
    Meier, Bernhard
    Greiner, Roger-Axel
    SWISS MEDICAL WEEKLY, 2013, 143
  • [4] Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia
    Mejia, Aurelio
    Manuel, Juan, Sr.
    Ceballos, Mateo
    Atehortua, Sara
    Manuel Toro, Juan
    Saldarriaga, Clara
    Elena Mejia, Maria
    Ramirez, Carolina
    BIOMEDICA, 2015, 35 (04): : 531 - 540
  • [5] COST-EFFECTIVENESS OF TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO STUDY: A CANADIAN ANALYSIS
    Mittmann, N.
    Chan, B.
    Seung, S. J.
    Liovas, A.
    Cohen, E.
    VALUE IN HEALTH, 2011, 14 (07) : A378 - A379
  • [6] COST-EFFECTIVENESS OF TICAGRELOR VERSUS GENERIC CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES IN CANADA
    Grima, D. T.
    Brown, S. T.
    Kamboj, L.
    Bainey, K.
    Goeree, R.
    Oh, P.
    Ramanathan, K.
    Goodman, S.
    VALUE IN HEALTH, 2013, 16 (03) : A285 - A285
  • [7] ECONOMIC EVALUATION OF TICAGRELOR IN TREATING PATIENTS WITH ACUTE CORONARY SYNDROME IN HONG KONG: A COST-UTILITY ANALYSIS
    Wu, D. B. C.
    Lee, B. S. C.
    Lee, K. K.
    VALUE IN HEALTH, 2013, 16 (03) : A289 - A289
  • [8] COST ANALYSIS OF TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME IN RUSSIA
    Pyadushkina, E. A.
    Gerasimova, K., V
    Avxentyeva, M.
    Krysanov, I
    VALUE IN HEALTH, 2012, 15 (07) : A366 - A366
  • [9] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Theidel, Ulrike
    Asseburg, Christian
    Giannitsis, Evangelos
    Katus, Hugo
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 447 - 458
  • [10] COST EFFECTIVENESS ANALYSIS OF TICAGRELOR VERSUS GENERIC CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN SPAIN
    Capel, M.
    Lopez-Sendon, J. L.
    Heras, M.
    Carrera, F. J.
    Brosa, M.
    VALUE IN HEALTH, 2014, 17 (07) : A491 - A491